Last reviewed · How we verify

NCT03571386: MBI

Mechanisms of Mindfulness-based Interventions

Completed Results posted Last updated 31 January 2025
What this trial tests

trial testing Mindfulness-based Cognitive Therapy (MBCT) in Depression in 136 participants. Completed in 30 September 2022.

Timeline
8 January 2019
Primary endpoint
2 July 2021
30 September 2022

Quick facts

Lead sponsorVanderbilt University Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment136
Start date8 January 2019
Primary completion2 July 2021
Estimated completion30 September 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 18 to 55, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in BOLD (Blood-oxygen-level-dependent) Mean Signal Change From Baseline to 12 Weeks in Response to Emotional (vs. Neutral) Word Stimuli Primary · Baseline to 12 weeks

fMRI BOLD response to emotional word stimuli baseline to 12 weeks (post-MBCT). BOLD signal change (pre- to post-MBCT) is estimated from the contrast of emotional word vs neutral words, and extracted from voxels within the fronto-parietal and default mode areas at baseline and 12-weeks. Significant Voxel-wise BOLD activity is reported using z-scores from peak voxels. A mean score was calculated based on z-score and SD of 2 in the context of reporting fMRI BOLD data here. Z-scores is a statistical measure that describes how many standard deviations a data point (e.g., a voxel's signal) is from t

BOLD - Right Frontopolar Cortex |
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety2.315± .5
BOLD - Right Dorsolateral PFC |
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety2.13± .5
BOLD - Left Precuneus |
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety-2.255± .5
Amplitude of P1 Event-related Potentials (ERP) in Response to Threat (vs. Neutral) Face Cues Pre- to Post-MBCT Secondary · Baseline to 12 weeks (pre- to post-MBCT)

P1 Evoked event-related electrical potentials (ERP) amplitudes elicited from specific emotional threat vs. neutral stimuli were primary outcome. An 80-150 ms search window at EEG electrode P8 was used to identify the P1 peak, \& mean value around peaks (50 ms) was exported for analysis. Mean P1-Cue amplitudes were analyzed pre- to post-MBCT to determine the effects of time (pre to post-MBCT), emotion (angry vs. happy), and congruency (congruent vs. incongruent). Mean P1-Cue amplitudes in microvolts and SD for each condition are summarized below.

Mean amplitude (uv) and standard deviations for Angry Cues pre-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety2.62± 2.83
Mean amplitude (uv) and standard deviations for Angry Cues post-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety2.60± 2.74
Mean amplitude (uv) and standard deviations for Happy Cues pre-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety2.68± 2.81
Mean amplitude (uv) and standard deviations for Happy Cues post-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety2.58± 2.73
Mean amplitude (uv) and standard deviations for Angry Congruent Cues pre-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety1.19± 2.32
Mean amplitude (uv) and standard deviations for Angry Congruent Cues post-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety.87± 1.97
Mean amplitude (uv) and standard deviations for Angry Incongruent Cues pre-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety1.16± 2.30
Mean amplitude (uv) and standard deviations for Angry Incongruent Cues post-MBCT
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety.61± 2.24
Response Time to Probes as a Function of Emotion and Congruency in the Dot Probe Task Secondary · Baseline to ~12 weeks

Effects of time (pre-MBCT versus post-MBCT), emotion (angry versus happy), and congruency (congruent probes versus incongruent probes) on reaction time (RT) was measured in mild to moderate depression/anxiety group.

RT to probes congruent with angry emotional stimuli pre-MBCT | unit of measure: mean RT & SE)
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety303.50± 1.2
RT to probes congruent with angry emotional stimuli post-MBCT | unit of measure: mean RT & SE
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety298.30± 1.2
RT to probes incongruent with angry emotional stimuli pre-MBCT | unit of measure: mean RT & SE
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety304.51± 1.3
RT to probes incongruent with angry emotional stimuli post-MBCT | unit of measure: mean RT & SE
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety301.29± 1.5
RT to probes congruent with happy emotional stimuli pre-MBCT | unit of measure: mean RT & SE
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety301.47± 1.4
RT to probes congruent with happy emotional stimuli post-MBCT | unit of measure: mean RT & SE
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety297.5± 1.3
RT to probes incongruent with happy emotional stimuli pre-MBCT | unit of measure: mean RT & SE
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety304.22± 1.2
RT to probes incongruent with happy emotional stimuli post-MBCT | unit of measure: mean RT & SE
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety301.38± 1.1
Self-report Psychological Measures of Anxiety and Stress Pre- to Post-Mindfulness Training Secondary · Baseline to ~12 weeks pre- to post-MBCT (depression/anxiety cohort)

The Depression \& Anxiety Stress Scale (DASS-Anxiety) (Lovibond and Lovibond, 1995) is a 7-item measure designed to assess symptoms of fear and autonomic arousal. Items are rated on a 4-point scale, ranging from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time), and summed to compute the total scale (range 0-21). Higher scores are indicative of greater symptom severity, with scores greater than 10 typically considered of clinical significance. The DASS-Depression is a 7-item measure designed to assess dysphoric mood. Items are rated on a 4-point Likert scale, ra

DASS-D scores pre- to post-MBCT | Mean change scores, (SE)
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety7.96± 1.41
DASS-A mean change pre- to post-MBCT | mean change, (SE)
GroupValue95% CI
Mild to Moderate Depression and/or Anxiety3.68± 1.28
Self-report Psychological Measures of Stress Pre- to Post-Mindfulness Training Secondary · Baseline to ~12 weeks pre- to post-MBSR (high stress cohort)

The Perceived Stress Scale (PSS-14) is a 14-item scale, with a total range from 0 (no symptoms) to 56 (highest severity) Higher scores are indicative of greater symptom severity, with scores greater than 10 typically considered of clinical significance.

GroupValue95% CI
High Stress-7.4± 2.3

Sponsor's own description

Mindfulness-based Interventions (MBIs) are a family of standardized cognitive and behavioral therapies that focus on cultivating mindfulness-related skills for improving maladaptive cognitive, emotional, and behavioral processes. MBIs have been developed for a wide range of problems, disorders, and populations and are increasingly available in a variety of health settings. This mixed methods study proposes to investigate proposed neurobiological, physiological, psycho-social-behavioral, and cognitive mechanisms by which MBIs may improve health outcomes.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. A Preliminary Investigation of ERP Components of Attentional Bias in Anxious Adults using Temporospatial Principal Component Analysis.
    Gupta RS, Kujawa A, Vago DR. · · 2021 · cited 5× · PMID 34732969 · DOI 10.1027/0269-8803/a000275
  2. Mindfulness-Based Cognitive Therapy: A Preliminary Examination of the (Event-Related) Potential for Modifying Threat-Related Attentional Bias in Anxiety.
    Gupta RS, Kujawa A, Fresco DM, Kang H, et al · · 2022 · cited 2× · PMID 35668874 · DOI 10.1007/s12671-022-01910-x

Verify or expand the search:

Other trials of Mindfulness-based Cognitive Therapy (MBCT)

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03571386.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing